1[1]Patrick S,Robert N.The clinical epidemiology of cardiac disease in chronic renal failure .Am J Nephrol, 1999, 10: 1606-1615
2[2]Rosario Maiorca, Giovanni C. Text book of peritoneal dialysis.lst Editior, Kluwer Academic publishers, 1994, 699-734
3[3]Colin B,kate D,David WH.Premature cardiovascular disease in chronic renal failure.The lancet, 2000 July 8, 356: 147-52
4[4]Manske CL,Thomas W,wang Y,et al. Screening diabetic transplant candidates for coronary artery disease:Identification of a low-risk subgroup. Kidney Int , 1993, 44: 617-621
5[5]Robert N,Patick S, Partfrey, et al. Impact of hypertension on cardionmyopathy, morbidity and mortality in end stage renal disease.Kidney Int, 1996, 49: 1379-1385
6[6]Rober N, Patick S, Parfrey, John, et al. The impact of anemia on cardiomyophy, morbidity and mortality in end stage renal disease .Am J kidney Dis, 1996, 28No1: pp53-61
7[7]Levin, Thompson CR, Ethier J,et al. Left ventricular mass index in early renal disease. Impact of decline in hemoglobin. Am J Kideny Dis, 1999, 34: 125-134
8[8]Galli-F, Canestari-F, Buoncristiani-U. Biological effects of oxidant stress in haemodialysis: the possible roles of vitamin E.Blood -Purif, 1999, (2-3): 79-94
9[9]Canaud-B, Cristol-J, Morena-M, et al. Imbalance of oxidants and antioxidants in haemodialysis patients. Blood-Purif, 1999, 17(2-3): 99-106
10[10]Panichi-V,Migliori-M,De-Pietro-S,et al. The link of bilcompatibility to cytokine production. Kindeny Int, 2000 Aug;58suppl 76:S96-103
